United States· US:72189-560_1b42a7cf-86d9-e506-e063-6394a90a3c9b
Lamotrigine ER
A lamotrigine product containing lamotrigine, registered in United States by Direct_rx. The same ATC class is registered in 18 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Lamotrigine is registered in 18 of 19 countries.
Countries holding a registration under ATC N03AX09 (lamotrigine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 10 of them publish a price we can compare per daily dose
Lamotrigine · ATC N03AX09
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of lamotrigine costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), the median price runs from $0.14 in United States to $4.21 in Switzerland — a ×30 gap.
- United States: $0.14 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Lamotrigine · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- CH Switzerland$4.21
- IT Italy$2.00
- FR France$1.69
- US United States$0.14 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- LAMOTRIGINE
- Manufacturer
- Direct_rx
- Country
- United States (US)
- ATC code
- N03AX09
- ATC class
- Lamotrigine
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11721895603030 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (72189-560-30)
- ndc1172189-560-30
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
248 interactions on record for lamotrigine.
Graded by severity as the source publishes them — 68 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lamotrigine · interactions on record
248 records
- 68 moderate
- 9 minor
- 129 info
Most severe, free to view
- MetoclopramideA03FA01moderate
- DiphenhydraminA04AB05moderate
- DronabinolA04AD10moderate
- NabiloneA04AD11moderate
42 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Lamotrigine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomLamictal 100mg dispersible tabletsPilsco Ltd
- CzechiaLAMICTALGlaxoSmithKline Trading Services Limited, Dublin
- SwedenLamictal 100 mg TablettMedartuum AB
- FinlandLamictalOrifarm Oy
- SpainCRISOMET 100 mg COMPRIMIDOS MASTICABLES/DISPERSABLESGlaxosmithkline S.A.
- BelgiumLambipol 100 mgGlaxoSmithKline Pharmaceuticals
- NetherlandsLambipol 100 mg, kauwtabletten/dispergeerbare tablettenGlaxoSmithKline B.V.
- IrelandLamictal 100 mg chewable/dispersible tabletsPCO Manufacturing Ltd.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Gerolamic, Lamictal
- Belgium · Lambipol, Lamictal
- Bulgaria · Епитрижин, Ламиктал
- Cyprus · Lamictal, Lamosynt
- Czechia · Lamictal, Lamotrigin Actavis
- Germany · Lamictal, Lamotrigin 1 A Pharma
- Denmark · Lamictal, Lamotrigin
- Estonia · Lamictal, Lamotrigine Desitin
- Spain · Crisomet, Labileno
- Finland · Lamictal, Lamotrigin Desitin
- France · Lamictal, Lamotrigine
- United Kingdom (Northern Ireland) · Lamictal, Lamotrigine
- Greece · Dezepil, Lamictal
- Croatia · Arvind, Lamal
- Hungary · Gerolamic, Lamictal
- Ireland · Lamictal, Lamotrigine Desitin
- Iceland · Lamictal
- Italy · Amaless, Lamictal
- Lithuania · Lamictal
- Luxembourg · Lambipol, Lamictal
- Latvia · Lamictal, Lamotrix
- Malta · Lamictal, Lamotrigine Aurobindo
- Netherlands · Lambipol, Lamictal
- Norway · Lamictal, Lamotrigin Desitin
- Poland · Epitrigine, Lamilept
- Portugal · Lamictal, Lamotrigina Accord
- Romania · Lamictal, Lamotrix
- Sweden · Lamictal, Lamotrigin
- Slovenia · Lamal, Lamictal
- Slovakia · Lamictal, Lamotrigin Actavis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ea54c732-056b-440d-8341-8fb7d4c5a28f GET /v1/drugs/ea54c732-056b-440d-8341-8fb7d4c5a28f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "200",
"substance": "LAMOTRIGINE",
"productndc": "72189-560",
"dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA213949",
"marketing_category": "ANDA"
}See everything about lamotrigine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.